Determination of Regulatory Review Period for Purposes of Patent Extension; ALFAPUMP
Published Date: 2/6/2026
Notice
Summary
The FDA has officially set the review period for the ALFAPUMP medical device, which helps the company apply for extra patent time. This means the device’s makers could get more time to protect their invention, potentially boosting their business. Anyone interested has until April 7, 2026, to share their thoughts with the FDA before the decision is final.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in